Ark Medical Solutions (ArkMS) will participate in BioJapan 2026 at the Alfresa Holdings Corporation booth. There, ArkMS will introduce PATH-Solution*, a platform supporting overseas biopharmaceutical companies seeking to enter and expand in the Japanese market.
ArkMS contributes its expertise in clinical development and post-marketing surveillance (PMS), working alongside the broader capabilities of the Alfresa Group and its alliance partners.
At BioJapan 2026, ArkMS will be at Booth D-108 together with Alfresa Group companies. ArkMS will introduce PATH-Solution and discuss potential opportunities with companies exploring business in the Japanese market.
Event Information
- Event BioJapan 2026
- Dates October 7–9, 2026
- Venue Pacifico Yokohama, Japan
- Booth D-108
We look forward to meeting you at BioJapan 2026.
For more information about PATH-Solution, please visit:
PATH-Solution | Alfresa Holdings Corporation